{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:51:25Z","timestamp":1792497085849,"version":"4.5.0"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants associated with a small increased risk of major bleeding. However, the risk of bleeding associated with the concomitant use of SSRIs and oral anticoagulants (OACs) has not been well characterized.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To assess whether concomitant use of SSRIs with OACs is associated with an increased risk of major bleeding compared with OAC use alone, describe how the risk varies with duration of use, and identify key clinical characteristics modifying this risk.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A population-based, nested case-control study was conducted among patients with atrial fibrillation initiating OACs between January 2, 1998, and March 29, 2021. Patients were from approximately 2000 general practices in the UK contributing to the Clinical Practice Research Datalink. With the use of risk-set sampling, for each case of major bleeding during follow-up, up to 30 controls were selected from risk sets defined by the case and matched on age, sex, cohort entry date, and follow-up duration.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Concomitant use of SSRIs and OACs (direct OACs and vitamin K antagonists [VKAs]) compared with OAC use alone.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was incidence rate ratios (IRRs) of hospitalization for bleeding or death due to bleeding.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n There were 42\u202f190 patients with major bleeding (mean [SD] age, 74.2 [9.3] years; 59.8% men) matched to 1\u202f156\u202f641 controls (mean [SD] age, 74.2 [9.3] years; 59.8% men). Concomitant use of SSRIs and OACs was associated with an increased risk of major bleeding compared with OACs alone (IRR, 1.33; 95% CI, 1.24-1.42). The risk peaked during the initial months of treatment (first 30 days of use: IRR, 1.74; 95% CI, 1.37-2.22) and persisted for up to 6 months. The risk did not vary with age, sex, history of bleeding, chronic kidney disease, and potency of SSRIs. An association was present both with concomitant use of SSRIs and direct OACs compared with direct OAC use alone (IRR, 1.25; 95% CI, 1.12-1.40) and concomitant use of SSRIs and VKAs compared with VKA use alone (IRR, 1.36; 95% CI, 1.25-1.47).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study suggests that among patients with atrial fibrillation, concomitant use of SSRIs and OACs was associated with an increased risk of major bleeding compared with OAC use alone, requiring close monitoring and management of risk factors for bleeding, particularly in the first few months of use.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.3208","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:32:18Z","timestamp":1711107138000},"page":"e243208","source":"Crossref","is-referenced-by-count":59,"title":["Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding"],"prefix":"10.1001","volume":"7","author":[{"given":"Alvi A.","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Department of Pediatrics, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beradid","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Boivin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Rej","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Renoux","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"issue":"5","key":"zoi240142r2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/11589340-000000000-00000","article-title":"Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.","volume":"28","author":"de Abajo","year":"2011","journal-title":"Drugs Aging"},{"issue":"1","key":"zoi240142r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate.","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"issue":"7217","key":"zoi240142r4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","article-title":"Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.","volume":"319","author":"de Abajo","year":"1999","journal-title":"BMJ"},{"issue":"7314","key":"zoi240142r5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/bmj.323.7314.655","article-title":"Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study.","volume":"323","author":"van Walraven","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"zoi240142r6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.","volume":"163","author":"Dalton","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi240142r7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jamaneurol.2016.4529","article-title":"Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage.","volume":"74","author":"Renoux","year":"2017","journal-title":"JAMA Neurol"},{"issue":"19","key":"zoi240142r8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1001\/archinte.163.19.2354","article-title":"Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.","volume":"163","author":"Movig","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi240142r9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/JCP.0b013e318166c52e","article-title":"The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants.","volume":"28","author":"Salkeld","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"18","key":"zoi240142r10","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/WNL.0b013e318271f848","article-title":"Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis.","volume":"79","author":"Hackam","year":"2012","journal-title":"Neurology"},{"key":"zoi240142r11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies.","volume":"118","author":"Laporte","year":"2017","journal-title":"Pharmacol Res"},{"issue":"12","key":"zoi240142r12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.","volume":"71","author":"Andrade","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"zoi240142r13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.","volume":"13","author":"Jiang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"zoi240142r14","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1111\/jth.12757","article-title":"Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.","volume":"12","author":"Lindqvist","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"zoi240142r15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40263-018-0507-7","article-title":"Risk of intracranial hemorrhage associated with the use of antidepressants inhibiting serotonin reuptake: a systematic review.","volume":"32","author":"Douros","year":"2018","journal-title":"CNS Drugs"},{"issue":"8","key":"zoi240142r16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007814","article-title":"Anxiety, depression, and adverse clinical outcomes in patients with atrial fibrillation starting warfarin: Cardiovascular Research Network WAVE Study.","volume":"7","author":"Baumgartner","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"zoi240142r17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/01.jcp.0000186869.67418.bc","article-title":"Antidepressants, warfarin, and the risk of hemorrhage.","volume":"25","author":"Kurdyak","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"zoi240142r18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cpt.v107.1","article-title":"Concomitant anticoagulant and antidepressant therapy in atrial fibrillation patients and risk of stroke and bleeding.","volume":"107","author":"Komen","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"zoi240142r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021447","article-title":"Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.","volume":"6","author":"Schelleman","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"zoi240142r20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008755","article-title":"Selective serotonin reuptake inhibitors and bleeding risk in anticoagulated patients with atrial fibrillation: an analysis from the ROCKET AF trial.","volume":"7","author":"Quinn","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"zoi240142r21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/FTD.0b013e318224996e","article-title":"Bleeding incidence with concomitant use of antidepressants and warfarin.","volume":"33","author":"Cochran","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"9","key":"zoi240142r22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3349\/ymj.2020.61.9.741","article-title":"Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding.","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med J"},{"issue":"4","key":"zoi240142r23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00392-019-01526-7","article-title":"Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non\u2013vitamin K antagonist oral anticoagulants based on two nested case-control studies.","volume":"109","author":"Jobski","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"zoi240142r24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/bcp.v86.6","article-title":"Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population-based nested case-control study.","volume":"86","author":"Zhang","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"zoi240142r25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/a-1932-8976","article-title":"Concomitant use of selective serotonin reuptake inhibitors and oral anticoagulants and risk of major bleeding: a systematic review and meta-analysis.","volume":"123","author":"Rahman","year":"2023","journal-title":"Thromb Haemost"},{"issue":"3","key":"zoi240142r26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD).","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi240142r27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum.","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi240142r28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ije\/dyx015","article-title":"Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC).","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi240142r30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"issue":"4","key":"zoi240142r31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0002-8703(03)00512-X","article-title":"The nested case-control study in cardiology.","volume":"146","author":"Essebag","year":"2003","journal-title":"Am Heart J"},{"issue":"392","key":"zoi240142r32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/1472-6963-12-392","article-title":"Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality.","volume":"12","author":"Crooks","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"zoi240142r33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","article-title":"Systematic review of discharge coding accuracy.","volume":"34","author":"Burns","year":"2012","journal-title":"J Public Health (Oxf)"},{"issue":"7","key":"zoi240142r34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/pds.v28.7","article-title":"Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.","volume":"28","author":"Shehab","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"zoi240142r36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-5-5","article-title":"Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure.","volume":"5","author":"Essebag","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"zoi240142r37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/jech-2022-219200","article-title":"Completeness and representativeness of small area socioeconomic data linked with the UK Clinical Practice Research Datalink (CPRD).","volume":"76","author":"Mahadevan","year":"2022","journal-title":"J Epidemiol Community Health"},{"issue":"2-3","key":"zoi240142r38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters.","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"zoi240142r39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings.","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"zoi240142r40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1017\/S146114570000198X","article-title":"Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.","volume":"3","author":"Javors","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"zoi240142r41","doi-asserted-by":"publisher","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction.","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"issue":"5","key":"zoi240142r44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi240142r45","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"zoi240142r46","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation.","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"issue":"4","key":"zoi240142r47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/pds.v26.4","article-title":"Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.","volume":"26","author":"Suissa","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"zoi240142r48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/EDE.0000000000001628","article-title":"The prevalent new-user design for studies with no active comparator: the example of statins and cancer.","volume":"34","author":"Suissa","year":"2023","journal-title":"Epidemiology"},{"issue":"9","key":"zoi240142r49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder, section 3: pharmacological treatments.","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"10","key":"zoi240142r51","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non\u2013vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"2","key":"zoi240142r52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archinternmed.2007.32","article-title":"Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins.","volume":"168","author":"Schalekamp","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5","key":"zoi240142r53","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"1","key":"zoi240142r54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis.","volume":"9","author":"Halperin","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"issue":"7","key":"zoi240142r55","first-page":"24","article-title":"Warfarin and antidepressants: happiness without hemorrhaging.","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"zoi240142r56","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fneur.2018.01067","article-title":"Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs.","volume":"9","author":"Galgani","year":"2018","journal-title":"Front Neurol"},{"issue":"21","key":"zoi240142r57","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding.","volume":"320","author":"Ray","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"zoi240142r59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/heartjnl-2018-312977","article-title":"Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.","volume":"105","author":"Adderley","year":"2019","journal-title":"Heart"},{"key":"zoi240142r1","volume-title":"Antidepressant Use Among Adults: United States, 2015-2018","author":"Brody","year":"2020"},{"key":"zoi240142r35","volume-title":"Pharmacoepidemiology","author":"Schneeweiss","year":"2020","edition":"6th ed"},{"key":"zoi240142r42","volume-title":"Epidemiology: An Introduction","author":"Rothman","year":"2012","edition":"2nd ed"},{"key":"zoi240142r29","unstructured":"Office for National Statistics. What we do. Accessed April 15, 2023. https:\/\/www.ons.gov.uk\/aboutus\/whatwedo"},{"key":"zoi240142r43","unstructured":"Raghunathan? TE, Lepkowski? JM, Van Hoewyk? J, Solenberger? P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27(1):85-95."},{"key":"zoi240142r50","unstructured":"Gelenberg? AJ, Freeman? MP, Markowitz? JC, . Practice guideline for the treatment of patients with major depressive disorder. American Psychiatric Association. 2010. Accessed April 30, 2023. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf"},{"key":"zoi240142r58","unstructured":"National Institute for Health and Care Excellence. Depression in adults: treatment and management. 2022. Accessed April 30, 2023. https:\/\/www.nice.org.uk\/guidance\/ng222"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2816687\/rahman_2024_oi_240142_1710523887.19892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:32:26Z","timestamp":1711107146000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2816687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.3208","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}